GPs to diagnose and prescribe for ADHD under ‘breakthrough’ plan West Australian GPs could soon be allowed to diagnose, initiate and manage treatment with stimulant medications.
Study compares Mounjaro to Wegovy for weight loss A new clinical trial, sponsored by the manufacturer, found Mounjaro led to greater weight loss, but GPs warn of its ‘risks of biases’.
Wegovy approved for cutting cardiovascular disease risk The TGA has approved semaglutide (sold as Wegovy) as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in overweight and obese adults.
Research provides hope for type 1 diabetes ‘cure’ Further trials are needed, but the use of rare cancer drugs to assist in restoring insulin production is showing promise.
Examining the pros and cons of semaglutide A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
RSV vaccine added to national program To ensure ‘every single infant in Australia is protected’, a $174.5 million investment will see free vaccines for pregnant people available nationwide.
‘Convincing’ evidence the pill can cause depression And some types are worse than others, writes psychiatrist Professor Jayashri Kulkarni.
‘Unprecedented’ update to antibiotic guidelines The first tranche of a major update from Therapeutic Guidelines has been released, with a focus on infections treated in primary care.
Osteoporosis guidelines updated for first time since 2017 The new guide will ‘make a real difference’ for the more than half of Australians aged over 50 with osteoporosis and osteopenia.
‘A wake-up call’: GPs issued warning over semaglutide prescribing The DoHAC has delivered ‘education letters’ to more than 1000 doctors found to be prescribing the medication under the PBS, but failing to follow the criteria.